nodes	percent_of_prediction	percent_of_DWPC	metapath
Estropipate—ESR1—ovarian cancer	0.589	1	CbGaD
Estropipate—ESR2—ovarian follicle—ovarian cancer	0.0168	0.201	CbGeAlD
Estropipate—ESR1—ovarian follicle—ovarian cancer	0.0115	0.138	CbGeAlD
Estropipate—ESR2—oviduct—ovarian cancer	0.00737	0.0883	CbGeAlD
Estropipate—CYP3A4—Topotecan—ovarian cancer	0.00588	0.272	CbGbCtD
Estropipate—ESR1—oviduct—ovarian cancer	0.00505	0.0605	CbGeAlD
Estropipate—CYP2C9—Paclitaxel—ovarian cancer	0.00501	0.232	CbGbCtD
Estropipate—CYP3A4—Vinorelbine—ovarian cancer	0.00414	0.192	CbGbCtD
Estropipate—CYP3A4—Paclitaxel—ovarian cancer	0.00291	0.135	CbGbCtD
Estropipate—CYP3A4—Docetaxel—ovarian cancer	0.0021	0.0974	CbGbCtD
Estropipate—ESR2—epithelium—ovarian cancer	0.00185	0.0222	CbGeAlD
Estropipate—ESR2—uterine cervix—ovarian cancer	0.00183	0.022	CbGeAlD
Estropipate—ESR2—endometrium—ovarian cancer	0.00166	0.0199	CbGeAlD
Estropipate—ESR1—myometrium—ovarian cancer	0.00161	0.0194	CbGeAlD
Estropipate—SHBG—endometrium—ovarian cancer	0.00161	0.0193	CbGeAlD
Estropipate—CYP3A4—Doxorubicin—ovarian cancer	0.00157	0.0726	CbGbCtD
Estropipate—ESR1—embryo—ovarian cancer	0.00155	0.0186	CbGeAlD
Estropipate—ESR2—gonad—ovarian cancer	0.00154	0.0184	CbGeAlD
Estropipate—ESR2—uterus—ovarian cancer	0.00153	0.0183	CbGeAlD
Estropipate—SHBG—gonad—ovarian cancer	0.0015	0.0179	CbGeAlD
Estropipate—SHBG—uterus—ovarian cancer	0.00149	0.0178	CbGeAlD
Estropipate—ESR2—female reproductive system—ovarian cancer	0.00137	0.0165	CbGeAlD
Estropipate—SHBG—female reproductive system—ovarian cancer	0.00134	0.016	CbGeAlD
Estropipate—ESR1—epithelium—ovarian cancer	0.00127	0.0152	CbGeAlD
Estropipate—SHBG—bone marrow—ovarian cancer	0.00126	0.0151	CbGeAlD
Estropipate—ESR1—uterine cervix—ovarian cancer	0.00126	0.0151	CbGeAlD
Estropipate—ESR2—female gonad—ovarian cancer	0.00125	0.015	CbGeAlD
Estropipate—ESR2—vagina—ovarian cancer	0.00124	0.0149	CbGeAlD
Estropipate—SHBG—female gonad—ovarian cancer	0.00122	0.0146	CbGeAlD
Estropipate—SHBG—vagina—ovarian cancer	0.00121	0.0145	CbGeAlD
Estropipate—ESR1—decidua—ovarian cancer	0.0012	0.0143	CbGeAlD
Estropipate—Quinestrol—ESR1—ovarian cancer	0.00115	0.163	CrCbGaD
Estropipate—ESR1—endometrium—ovarian cancer	0.00114	0.0136	CbGeAlD
Estropipate—ESR2—testis—ovarian cancer	0.00111	0.0133	CbGeAlD
Estropipate—SHBG—testis—ovarian cancer	0.00108	0.0129	CbGeAlD
Estropipate—ESR1—gonad—ovarian cancer	0.00105	0.0126	CbGeAlD
Estropipate—ESR1—uterus—ovarian cancer	0.00105	0.0126	CbGeAlD
Estropipate—SLC22A1—vagina—ovarian cancer	0.00104	0.0125	CbGeAlD
Estropipate—ESR1—female reproductive system—ovarian cancer	0.000941	0.0113	CbGeAlD
Estropipate—ALB—testis—ovarian cancer	0.00089	0.0107	CbGeAlD
Estropipate—Mestranol—ESR1—ovarian cancer	0.000868	0.123	CrCbGaD
Estropipate—ESR1—female gonad—ovarian cancer	0.000856	0.0103	CbGeAlD
Estropipate—ESR1—vagina—ovarian cancer	0.000851	0.0102	CbGeAlD
Estropipate—ESR2—lymph node—ovarian cancer	0.000804	0.00964	CbGeAlD
Estropipate—ESR1—testis—ovarian cancer	0.00076	0.00911	CbGeAlD
Estropipate—Estriol—ESR1—ovarian cancer	0.000758	0.108	CrCbGaD
Estropipate—Estramustine—ESR1—ovarian cancer	0.000704	0.1	CrCbGaD
Estropipate—CYP2C9—female reproductive system—ovarian cancer	0.000689	0.00826	CbGeAlD
Estropipate—ALB—lymph node—ovarian cancer	0.000645	0.00774	CbGeAlD
Estropipate—ESR1—lymph node—ovarian cancer	0.000551	0.0066	CbGeAlD
Estropipate—Estrone—CYP1B1—ovarian cancer	0.000534	0.0758	CrCbGaD
Estropipate—CYP3A4—female reproductive system—ovarian cancer	0.000525	0.0063	CbGeAlD
Estropipate—Ethinyl Estradiol—ESR1—ovarian cancer	0.000414	0.0588	CrCbGaD
Estropipate—Estradiol—CYP1B1—ovarian cancer	0.000405	0.0574	CrCbGaD
Estropipate—Conjugated Estrogens—ESR1—ovarian cancer	0.000362	0.0513	CrCbGaD
Estropipate—Estrone—ESR1—ovarian cancer	0.000361	0.0512	CrCbGaD
Estropipate—Estriol—ABCB1—ovarian cancer	0.000322	0.0457	CrCbGaD
Estropipate—Estramustine—ABCB1—ovarian cancer	0.000299	0.0425	CrCbGaD
Estropipate—Estradiol—ESR1—ovarian cancer	0.000273	0.0388	CrCbGaD
Estropipate—Oedema peripheral—Docetaxel—ovarian cancer	0.000213	0.00101	CcSEcCtD
Estropipate—Diarrhoea—Melphalan—ovarian cancer	0.000211	0.001	CcSEcCtD
Estropipate—Pain in extremity—Epirubicin—ovarian cancer	0.00021	0.001	CcSEcCtD
Estropipate—Nausea—Chlorambucil—ovarian cancer	0.00021	0.000998	CcSEcCtD
Estropipate—Visual impairment—Docetaxel—ovarian cancer	0.000208	0.00099	CcSEcCtD
Estropipate—Dizziness—Topotecan—ovarian cancer	0.000208	0.000989	CcSEcCtD
Estropipate—Migraine—Epirubicin—ovarian cancer	0.000207	0.000986	CcSEcCtD
Estropipate—Erythema multiforme—Docetaxel—ovarian cancer	0.000204	0.000971	CcSEcCtD
Estropipate—Dermatitis bullous—Doxorubicin—ovarian cancer	0.000204	0.00097	CcSEcCtD
Estropipate—Angioedema—Paclitaxel—ovarian cancer	0.000202	0.000964	CcSEcCtD
Estropipate—Purpura—Doxorubicin—ovarian cancer	0.000202	0.000961	CcSEcCtD
Estropipate—Eye disorder—Docetaxel—ovarian cancer	0.000202	0.00096	CcSEcCtD
Estropipate—Anaphylactoid reaction—Doxorubicin—ovarian cancer	0.000201	0.000957	CcSEcCtD
Estropipate—Cardiac disorder—Docetaxel—ovarian cancer	0.0002	0.000953	CcSEcCtD
Estropipate—Vomiting—Topotecan—ovarian cancer	0.0002	0.000951	CcSEcCtD
Estropipate—Mood swings—Epirubicin—ovarian cancer	0.000199	0.000949	CcSEcCtD
Estropipate—Vertigo—Paclitaxel—ovarian cancer	0.000199	0.000948	CcSEcCtD
Estropipate—Cerebrovascular accident—Doxorubicin—ovarian cancer	0.000199	0.000946	CcSEcCtD
Estropipate—Rash—Topotecan—ovarian cancer	0.000198	0.000943	CcSEcCtD
Estropipate—Hypersensitivity—Vinorelbine—ovarian cancer	0.000198	0.000943	CcSEcCtD
Estropipate—Dermatitis—Topotecan—ovarian cancer	0.000198	0.000943	CcSEcCtD
Estropipate—Headache—Topotecan—ovarian cancer	0.000197	0.000937	CcSEcCtD
Estropipate—Palpitations—Paclitaxel—ovarian cancer	0.000196	0.000932	CcSEcCtD
Estropipate—Angiopathy—Docetaxel—ovarian cancer	0.000196	0.000932	CcSEcCtD
Estropipate—Vomiting—Melphalan—ovarian cancer	0.000196	0.000932	CcSEcCtD
Estropipate—Immune system disorder—Docetaxel—ovarian cancer	0.000195	0.000928	CcSEcCtD
Estropipate—Pain in extremity—Doxorubicin—ovarian cancer	0.000195	0.000927	CcSEcCtD
Estropipate—Mediastinal disorder—Docetaxel—ovarian cancer	0.000194	0.000926	CcSEcCtD
Estropipate—Rash—Melphalan—ovarian cancer	0.000194	0.000924	CcSEcCtD
Estropipate—Dermatitis—Melphalan—ovarian cancer	0.000194	0.000923	CcSEcCtD
Estropipate—Cough—Paclitaxel—ovarian cancer	0.000193	0.000921	CcSEcCtD
Estropipate—Asthenia—Vinorelbine—ovarian cancer	0.000193	0.000918	CcSEcCtD
Estropipate—Migraine—Doxorubicin—ovarian cancer	0.000192	0.000912	CcSEcCtD
Estropipate—Alopecia—Docetaxel—ovarian cancer	0.000191	0.000908	CcSEcCtD
Estropipate—Pruritus—Vinorelbine—ovarian cancer	0.00019	0.000906	CcSEcCtD
Estropipate—Breast disorder—Epirubicin—ovarian cancer	0.00019	0.000905	CcSEcCtD
Estropipate—Mental disorder—Docetaxel—ovarian cancer	0.000189	0.0009	CcSEcCtD
Estropipate—Arthralgia—Paclitaxel—ovarian cancer	0.000189	0.000898	CcSEcCtD
Estropipate—Myalgia—Paclitaxel—ovarian cancer	0.000189	0.000898	CcSEcCtD
Estropipate—Anxiety—Paclitaxel—ovarian cancer	0.000188	0.000895	CcSEcCtD
Estropipate—Erythema—Docetaxel—ovarian cancer	0.000188	0.000894	CcSEcCtD
Estropipate—Malnutrition—Docetaxel—ovarian cancer	0.000188	0.000894	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000187	0.000892	CcSEcCtD
Estropipate—Nausea—Topotecan—ovarian cancer	0.000187	0.000889	CcSEcCtD
Estropipate—Mood swings—Doxorubicin—ovarian cancer	0.000184	0.000878	CcSEcCtD
Estropipate—Diarrhoea—Vinorelbine—ovarian cancer	0.000184	0.000876	CcSEcCtD
Estropipate—Abdominal distension—Epirubicin—ovarian cancer	0.000183	0.000871	CcSEcCtD
Estropipate—Nausea—Melphalan—ovarian cancer	0.000183	0.00087	CcSEcCtD
Estropipate—Asthma—Epirubicin—ovarian cancer	0.000182	0.000866	CcSEcCtD
Estropipate—Influenza—Epirubicin—ovarian cancer	0.000182	0.000866	CcSEcCtD
Estropipate—Back pain—Docetaxel—ovarian cancer	0.000182	0.000865	CcSEcCtD
Estropipate—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000181	0.000861	CcSEcCtD
Estropipate—Oedema—Paclitaxel—ovarian cancer	0.000181	0.000861	CcSEcCtD
Estropipate—Muscle spasms—Docetaxel—ovarian cancer	0.000181	0.00086	CcSEcCtD
Estropipate—Infection—Paclitaxel—ovarian cancer	0.00018	0.000855	CcSEcCtD
Estropipate—Pancreatitis—Epirubicin—ovarian cancer	0.000178	0.000849	CcSEcCtD
Estropipate—Dizziness—Vinorelbine—ovarian cancer	0.000178	0.000846	CcSEcCtD
Estropipate—Nervous system disorder—Paclitaxel—ovarian cancer	0.000177	0.000844	CcSEcCtD
Estropipate—Breast disorder—Doxorubicin—ovarian cancer	0.000176	0.000837	CcSEcCtD
Estropipate—Ethinyl Estradiol—ABCB1—ovarian cancer	0.000176	0.025	CrCbGaD
Estropipate—Skin disorder—Paclitaxel—ovarian cancer	0.000176	0.000836	CcSEcCtD
Estropipate—Vomiting—Vinorelbine—ovarian cancer	0.000171	0.000814	CcSEcCtD
Estropipate—Dysuria—Epirubicin—ovarian cancer	0.00017	0.000809	CcSEcCtD
Estropipate—Rash—Vinorelbine—ovarian cancer	0.00017	0.000807	CcSEcCtD
Estropipate—Dermatitis—Vinorelbine—ovarian cancer	0.000169	0.000806	CcSEcCtD
Estropipate—Abdominal distension—Doxorubicin—ovarian cancer	0.000169	0.000806	CcSEcCtD
Estropipate—Upper respiratory tract infection—Epirubicin—ovarian cancer	0.000169	0.000804	CcSEcCtD
Estropipate—Headache—Vinorelbine—ovarian cancer	0.000168	0.000802	CcSEcCtD
Estropipate—Asthma—Doxorubicin—ovarian cancer	0.000168	0.000801	CcSEcCtD
Estropipate—Influenza—Doxorubicin—ovarian cancer	0.000168	0.000801	CcSEcCtD
Estropipate—Palpitations—Docetaxel—ovarian cancer	0.000166	0.00079	CcSEcCtD
Estropipate—Weight increased—Epirubicin—ovarian cancer	0.000165	0.000788	CcSEcCtD
Estropipate—Pancreatitis—Doxorubicin—ovarian cancer	0.000165	0.000785	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000165	0.000784	CcSEcCtD
Estropipate—Hyperglycaemia—Epirubicin—ovarian cancer	0.000164	0.000781	CcSEcCtD
Estropipate—Cough—Docetaxel—ovarian cancer	0.000164	0.00078	CcSEcCtD
Estropipate—Insomnia—Paclitaxel—ovarian cancer	0.000164	0.000779	CcSEcCtD
Estropipate—Paraesthesia—Paclitaxel—ovarian cancer	0.000162	0.000773	CcSEcCtD
Estropipate—Infestation NOS—Epirubicin—ovarian cancer	0.000162	0.000772	CcSEcCtD
Estropipate—Infestation—Epirubicin—ovarian cancer	0.000162	0.000772	CcSEcCtD
Estropipate—Somnolence—Paclitaxel—ovarian cancer	0.000161	0.000765	CcSEcCtD
Estropipate—Myalgia—Docetaxel—ovarian cancer	0.00016	0.000761	CcSEcCtD
Estropipate—Arthralgia—Docetaxel—ovarian cancer	0.00016	0.000761	CcSEcCtD
Estropipate—Nausea—Vinorelbine—ovarian cancer	0.00016	0.00076	CcSEcCtD
Estropipate—Dyspepsia—Paclitaxel—ovarian cancer	0.000159	0.000758	CcSEcCtD
Estropipate—Neuropathy peripheral—Epirubicin—ovarian cancer	0.000159	0.000756	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000159	0.000756	CcSEcCtD
Estropipate—Dysuria—Doxorubicin—ovarian cancer	0.000157	0.000749	CcSEcCtD
Estropipate—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.000156	0.000744	CcSEcCtD
Estropipate—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000156	0.000743	CcSEcCtD
Estropipate—Fatigue—Paclitaxel—ovarian cancer	0.000156	0.000742	CcSEcCtD
Estropipate—Pain—Paclitaxel—ovarian cancer	0.000155	0.000736	CcSEcCtD
Estropipate—Constipation—Paclitaxel—ovarian cancer	0.000155	0.000736	CcSEcCtD
Estropipate—Conjugated Estrogens—ABCB1—ovarian cancer	0.000154	0.0218	CrCbGaD
Estropipate—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000153	0.00073	CcSEcCtD
Estropipate—Oedema—Docetaxel—ovarian cancer	0.000153	0.00073	CcSEcCtD
Estropipate—Anaphylactic shock—Docetaxel—ovarian cancer	0.000153	0.00073	CcSEcCtD
Estropipate—Estrone—ABCB1—ovarian cancer	0.000153	0.0217	CrCbGaD
Estropipate—Weight increased—Doxorubicin—ovarian cancer	0.000153	0.000729	CcSEcCtD
Estropipate—Infection—Docetaxel—ovarian cancer	0.000152	0.000725	CcSEcCtD
Estropipate—Sinusitis—Epirubicin—ovarian cancer	0.000152	0.000724	CcSEcCtD
Estropipate—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000152	0.000722	CcSEcCtD
Estropipate—Nervous system disorder—Docetaxel—ovarian cancer	0.00015	0.000716	CcSEcCtD
Estropipate—Infestation NOS—Doxorubicin—ovarian cancer	0.00015	0.000714	CcSEcCtD
Estropipate—Infestation—Doxorubicin—ovarian cancer	0.00015	0.000714	CcSEcCtD
Estropipate—Skin disorder—Docetaxel—ovarian cancer	0.000149	0.000709	CcSEcCtD
Estropipate—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000148	0.000704	CcSEcCtD
Estropipate—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000147	0.0007	CcSEcCtD
Estropipate—Rhinitis—Epirubicin—ovarian cancer	0.000146	0.000695	CcSEcCtD
Estropipate—Pharyngitis—Epirubicin—ovarian cancer	0.000144	0.000688	CcSEcCtD
Estropipate—Urticaria—Paclitaxel—ovarian cancer	0.000144	0.000684	CcSEcCtD
Estropipate—Oedema peripheral—Epirubicin—ovarian cancer	0.000143	0.000682	CcSEcCtD
Estropipate—Abdominal pain—Paclitaxel—ovarian cancer	0.000143	0.000681	CcSEcCtD
Estropipate—Body temperature increased—Paclitaxel—ovarian cancer	0.000143	0.000681	CcSEcCtD
Estropipate—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000142	0.000675	CcSEcCtD
Estropipate—Sinusitis—Doxorubicin—ovarian cancer	0.000141	0.00067	CcSEcCtD
Estropipate—Visual impairment—Epirubicin—ovarian cancer	0.00014	0.000668	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.00014	0.000665	CcSEcCtD
Estropipate—Insomnia—Docetaxel—ovarian cancer	0.000139	0.00066	CcSEcCtD
Estropipate—Paraesthesia—Docetaxel—ovarian cancer	0.000138	0.000655	CcSEcCtD
Estropipate—Erythema multiforme—Epirubicin—ovarian cancer	0.000138	0.000655	CcSEcCtD
Estropipate—Somnolence—Docetaxel—ovarian cancer	0.000136	0.000649	CcSEcCtD
Estropipate—Eye disorder—Epirubicin—ovarian cancer	0.000136	0.000647	CcSEcCtD
Estropipate—Cardiac disorder—Epirubicin—ovarian cancer	0.000135	0.000643	CcSEcCtD
Estropipate—Rhinitis—Doxorubicin—ovarian cancer	0.000135	0.000643	CcSEcCtD
Estropipate—Dyspepsia—Docetaxel—ovarian cancer	0.000135	0.000642	CcSEcCtD
Estropipate—Pharyngitis—Doxorubicin—ovarian cancer	0.000134	0.000636	CcSEcCtD
Estropipate—Hypersensitivity—Paclitaxel—ovarian cancer	0.000133	0.000634	CcSEcCtD
Estropipate—Oedema peripheral—Doxorubicin—ovarian cancer	0.000133	0.000631	CcSEcCtD
Estropipate—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000132	0.00063	CcSEcCtD
Estropipate—Fatigue—Docetaxel—ovarian cancer	0.000132	0.000629	CcSEcCtD
Estropipate—Angiopathy—Epirubicin—ovarian cancer	0.000132	0.000629	CcSEcCtD
Estropipate—Immune system disorder—Epirubicin—ovarian cancer	0.000131	0.000626	CcSEcCtD
Estropipate—Mediastinal disorder—Epirubicin—ovarian cancer	0.000131	0.000624	CcSEcCtD
Estropipate—Constipation—Docetaxel—ovarian cancer	0.000131	0.000624	CcSEcCtD
Estropipate—Pain—Docetaxel—ovarian cancer	0.000131	0.000624	CcSEcCtD
Estropipate—Visual impairment—Doxorubicin—ovarian cancer	0.00013	0.000618	CcSEcCtD
Estropipate—Asthenia—Paclitaxel—ovarian cancer	0.00013	0.000618	CcSEcCtD
Estropipate—Alopecia—Epirubicin—ovarian cancer	0.000129	0.000612	CcSEcCtD
Estropipate—Pruritus—Paclitaxel—ovarian cancer	0.000128	0.000609	CcSEcCtD
Estropipate—Mental disorder—Epirubicin—ovarian cancer	0.000127	0.000607	CcSEcCtD
Estropipate—Erythema multiforme—Doxorubicin—ovarian cancer	0.000127	0.000606	CcSEcCtD
Estropipate—Erythema—Epirubicin—ovarian cancer	0.000127	0.000603	CcSEcCtD
Estropipate—Malnutrition—Epirubicin—ovarian cancer	0.000127	0.000603	CcSEcCtD
Estropipate—Eye disorder—Doxorubicin—ovarian cancer	0.000126	0.000599	CcSEcCtD
Estropipate—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000125	0.000597	CcSEcCtD
Estropipate—Cardiac disorder—Doxorubicin—ovarian cancer	0.000125	0.000595	CcSEcCtD
Estropipate—Flatulence—Epirubicin—ovarian cancer	0.000125	0.000594	CcSEcCtD
Estropipate—Tension—Epirubicin—ovarian cancer	0.000124	0.000592	CcSEcCtD
Estropipate—Diarrhoea—Paclitaxel—ovarian cancer	0.000124	0.000589	CcSEcCtD
Estropipate—Nervousness—Epirubicin—ovarian cancer	0.000123	0.000586	CcSEcCtD
Estropipate—Back pain—Epirubicin—ovarian cancer	0.000123	0.000583	CcSEcCtD
Estropipate—Angiopathy—Doxorubicin—ovarian cancer	0.000122	0.000582	CcSEcCtD
Estropipate—Muscle spasms—Epirubicin—ovarian cancer	0.000122	0.00058	CcSEcCtD
Estropipate—Immune system disorder—Doxorubicin—ovarian cancer	0.000122	0.000579	CcSEcCtD
Estropipate—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000121	0.000578	CcSEcCtD
Estropipate—Abdominal pain—Docetaxel—ovarian cancer	0.000121	0.000577	CcSEcCtD
Estropipate—Body temperature increased—Docetaxel—ovarian cancer	0.000121	0.000577	CcSEcCtD
Estropipate—Dizziness—Paclitaxel—ovarian cancer	0.00012	0.000569	CcSEcCtD
Estropipate—Alopecia—Doxorubicin—ovarian cancer	0.000119	0.000566	CcSEcCtD
Estropipate—Mental disorder—Doxorubicin—ovarian cancer	0.000118	0.000562	CcSEcCtD
Estropipate—Erythema—Doxorubicin—ovarian cancer	0.000117	0.000558	CcSEcCtD
Estropipate—Malnutrition—Doxorubicin—ovarian cancer	0.000117	0.000558	CcSEcCtD
Estropipate—Estradiol—ABCB1—ovarian cancer	0.000116	0.0165	CrCbGaD
Estropipate—Flatulence—Doxorubicin—ovarian cancer	0.000115	0.00055	CcSEcCtD
Estropipate—Tension—Doxorubicin—ovarian cancer	0.000115	0.000548	CcSEcCtD
Estropipate—Vomiting—Paclitaxel—ovarian cancer	0.000115	0.000547	CcSEcCtD
Estropipate—Rash—Paclitaxel—ovarian cancer	0.000114	0.000543	CcSEcCtD
Estropipate—Dermatitis—Paclitaxel—ovarian cancer	0.000114	0.000542	CcSEcCtD
Estropipate—Nervousness—Doxorubicin—ovarian cancer	0.000114	0.000542	CcSEcCtD
Estropipate—Vertigo—Epirubicin—ovarian cancer	0.000114	0.000542	CcSEcCtD
Estropipate—Back pain—Doxorubicin—ovarian cancer	0.000113	0.00054	CcSEcCtD
Estropipate—Headache—Paclitaxel—ovarian cancer	0.000113	0.000539	CcSEcCtD
Estropipate—Hypersensitivity—Docetaxel—ovarian cancer	0.000113	0.000538	CcSEcCtD
Estropipate—Muscle spasms—Doxorubicin—ovarian cancer	0.000113	0.000536	CcSEcCtD
Estropipate—Palpitations—Epirubicin—ovarian cancer	0.000112	0.000533	CcSEcCtD
Estropipate—Cough—Epirubicin—ovarian cancer	0.000111	0.000526	CcSEcCtD
Estropipate—Asthenia—Docetaxel—ovarian cancer	0.00011	0.000524	CcSEcCtD
Estropipate—Pruritus—Docetaxel—ovarian cancer	0.000108	0.000516	CcSEcCtD
Estropipate—Myalgia—Epirubicin—ovarian cancer	0.000108	0.000513	CcSEcCtD
Estropipate—Arthralgia—Epirubicin—ovarian cancer	0.000108	0.000513	CcSEcCtD
Estropipate—Anxiety—Epirubicin—ovarian cancer	0.000107	0.000512	CcSEcCtD
Estropipate—Nausea—Paclitaxel—ovarian cancer	0.000107	0.000511	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000107	0.00051	CcSEcCtD
Estropipate—Vertigo—Doxorubicin—ovarian cancer	0.000105	0.000501	CcSEcCtD
Estropipate—Diarrhoea—Docetaxel—ovarian cancer	0.000105	0.000499	CcSEcCtD
Estropipate—Palpitations—Doxorubicin—ovarian cancer	0.000104	0.000493	CcSEcCtD
Estropipate—Anaphylactic shock—Epirubicin—ovarian cancer	0.000103	0.000492	CcSEcCtD
Estropipate—Oedema—Epirubicin—ovarian cancer	0.000103	0.000492	CcSEcCtD
Estropipate—Infection—Epirubicin—ovarian cancer	0.000103	0.000489	CcSEcCtD
Estropipate—Cough—Doxorubicin—ovarian cancer	0.000102	0.000487	CcSEcCtD
Estropipate—Nervous system disorder—Epirubicin—ovarian cancer	0.000101	0.000483	CcSEcCtD
Estropipate—Dizziness—Docetaxel—ovarian cancer	0.000101	0.000483	CcSEcCtD
Estropipate—Skin disorder—Epirubicin—ovarian cancer	0.0001	0.000478	CcSEcCtD
Estropipate—Myalgia—Doxorubicin—ovarian cancer	9.98e-05	0.000475	CcSEcCtD
Estropipate—Arthralgia—Doxorubicin—ovarian cancer	9.98e-05	0.000475	CcSEcCtD
Estropipate—Anxiety—Doxorubicin—ovarian cancer	9.94e-05	0.000473	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	9.91e-05	0.000472	CcSEcCtD
Estropipate—Vomiting—Docetaxel—ovarian cancer	9.75e-05	0.000464	CcSEcCtD
Estropipate—Rash—Docetaxel—ovarian cancer	9.66e-05	0.00046	CcSEcCtD
Estropipate—Dermatitis—Docetaxel—ovarian cancer	9.66e-05	0.00046	CcSEcCtD
Estropipate—Headache—Docetaxel—ovarian cancer	9.6e-05	0.000457	CcSEcCtD
Estropipate—Anaphylactic shock—Doxorubicin—ovarian cancer	9.57e-05	0.000455	CcSEcCtD
Estropipate—Oedema—Doxorubicin—ovarian cancer	9.57e-05	0.000455	CcSEcCtD
Estropipate—Infection—Doxorubicin—ovarian cancer	9.5e-05	0.000452	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Epirubicin—ovarian cancer	9.42e-05	0.000448	CcSEcCtD
Estropipate—Nervous system disorder—Doxorubicin—ovarian cancer	9.38e-05	0.000447	CcSEcCtD
Estropipate—Insomnia—Epirubicin—ovarian cancer	9.35e-05	0.000445	CcSEcCtD
Estropipate—Skin disorder—Doxorubicin—ovarian cancer	9.29e-05	0.000442	CcSEcCtD
Estropipate—Paraesthesia—Epirubicin—ovarian cancer	9.28e-05	0.000442	CcSEcCtD
Estropipate—Somnolence—Epirubicin—ovarian cancer	9.19e-05	0.000438	CcSEcCtD
Estropipate—Nausea—Docetaxel—ovarian cancer	9.1e-05	0.000433	CcSEcCtD
Estropipate—Dyspepsia—Epirubicin—ovarian cancer	9.1e-05	0.000433	CcSEcCtD
Estropipate—Gastrointestinal disorder—Epirubicin—ovarian cancer	8.93e-05	0.000425	CcSEcCtD
Estropipate—Fatigue—Epirubicin—ovarian cancer	8.91e-05	0.000424	CcSEcCtD
Estropipate—Pain—Epirubicin—ovarian cancer	8.84e-05	0.000421	CcSEcCtD
Estropipate—Constipation—Epirubicin—ovarian cancer	8.84e-05	0.000421	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	8.72e-05	0.000415	CcSEcCtD
Estropipate—Insomnia—Doxorubicin—ovarian cancer	8.65e-05	0.000412	CcSEcCtD
Estropipate—Paraesthesia—Doxorubicin—ovarian cancer	8.59e-05	0.000409	CcSEcCtD
Estropipate—Somnolence—Doxorubicin—ovarian cancer	8.5e-05	0.000405	CcSEcCtD
Estropipate—Gastrointestinal pain—Epirubicin—ovarian cancer	8.45e-05	0.000402	CcSEcCtD
Estropipate—Dyspepsia—Doxorubicin—ovarian cancer	8.42e-05	0.000401	CcSEcCtD
Estropipate—Gastrointestinal disorder—Doxorubicin—ovarian cancer	8.26e-05	0.000393	CcSEcCtD
Estropipate—Fatigue—Doxorubicin—ovarian cancer	8.25e-05	0.000393	CcSEcCtD
Estropipate—Urticaria—Epirubicin—ovarian cancer	8.21e-05	0.000391	CcSEcCtD
Estropipate—Pain—Doxorubicin—ovarian cancer	8.18e-05	0.000389	CcSEcCtD
Estropipate—Constipation—Doxorubicin—ovarian cancer	8.18e-05	0.000389	CcSEcCtD
Estropipate—Abdominal pain—Epirubicin—ovarian cancer	8.17e-05	0.000389	CcSEcCtD
Estropipate—Body temperature increased—Epirubicin—ovarian cancer	8.17e-05	0.000389	CcSEcCtD
Estropipate—Gastrointestinal pain—Doxorubicin—ovarian cancer	7.82e-05	0.000372	CcSEcCtD
Estropipate—Hypersensitivity—Epirubicin—ovarian cancer	7.62e-05	0.000363	CcSEcCtD
Estropipate—Urticaria—Doxorubicin—ovarian cancer	7.6e-05	0.000362	CcSEcCtD
Estropipate—Body temperature increased—Doxorubicin—ovarian cancer	7.56e-05	0.00036	CcSEcCtD
Estropipate—Abdominal pain—Doxorubicin—ovarian cancer	7.56e-05	0.00036	CcSEcCtD
Estropipate—Asthenia—Epirubicin—ovarian cancer	7.42e-05	0.000353	CcSEcCtD
Estropipate—Pruritus—Epirubicin—ovarian cancer	7.31e-05	0.000348	CcSEcCtD
Estropipate—Diarrhoea—Epirubicin—ovarian cancer	7.07e-05	0.000337	CcSEcCtD
Estropipate—Hypersensitivity—Doxorubicin—ovarian cancer	7.05e-05	0.000336	CcSEcCtD
Estropipate—Asthenia—Doxorubicin—ovarian cancer	6.86e-05	0.000327	CcSEcCtD
Estropipate—Dizziness—Epirubicin—ovarian cancer	6.84e-05	0.000325	CcSEcCtD
Estropipate—Pruritus—Doxorubicin—ovarian cancer	6.77e-05	0.000322	CcSEcCtD
Estropipate—Vomiting—Epirubicin—ovarian cancer	6.57e-05	0.000313	CcSEcCtD
Estropipate—Diarrhoea—Doxorubicin—ovarian cancer	6.54e-05	0.000312	CcSEcCtD
Estropipate—Rash—Epirubicin—ovarian cancer	6.52e-05	0.00031	CcSEcCtD
Estropipate—Dermatitis—Epirubicin—ovarian cancer	6.51e-05	0.00031	CcSEcCtD
Estropipate—Headache—Epirubicin—ovarian cancer	6.48e-05	0.000308	CcSEcCtD
Estropipate—Dizziness—Doxorubicin—ovarian cancer	6.33e-05	0.000301	CcSEcCtD
Estropipate—Nausea—Epirubicin—ovarian cancer	6.14e-05	0.000292	CcSEcCtD
Estropipate—Vomiting—Doxorubicin—ovarian cancer	6.08e-05	0.00029	CcSEcCtD
Estropipate—Rash—Doxorubicin—ovarian cancer	6.03e-05	0.000287	CcSEcCtD
Estropipate—Dermatitis—Doxorubicin—ovarian cancer	6.03e-05	0.000287	CcSEcCtD
Estropipate—Headache—Doxorubicin—ovarian cancer	5.99e-05	0.000285	CcSEcCtD
Estropipate—Nausea—Doxorubicin—ovarian cancer	5.68e-05	0.000271	CcSEcCtD
Estropipate—ESR2—Gene Expression—PPP2R1A—ovarian cancer	5.38e-05	0.000605	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—BCL9—ovarian cancer	5.37e-05	0.000604	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	5.35e-05	0.000602	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	5.3e-05	0.000596	CbGpPWpGaD
Estropipate—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—ovarian cancer	5.24e-05	0.000589	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	5.21e-05	0.000586	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	5.16e-05	0.00058	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—MAPK3—ovarian cancer	5.16e-05	0.00058	CbGpPWpGaD
Estropipate—ALB—Metabolism—NME2—ovarian cancer	5.12e-05	0.000576	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—ovarian cancer	5.09e-05	0.000573	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—MYC—ovarian cancer	5.04e-05	0.000567	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	5.03e-05	0.000565	CbGpPWpGaD
Estropipate—ALB—Transmembrane transport of small molecules—TUBB3—ovarian cancer	4.96e-05	0.000558	CbGpPWpGaD
Estropipate—SLC22A1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	4.95e-05	0.000557	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—CYTB—ovarian cancer	4.93e-05	0.000555	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—MAPK1—ovarian cancer	4.93e-05	0.000555	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—EGFR—ovarian cancer	4.93e-05	0.000554	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—MAPK1—ovarian cancer	4.91e-05	0.000552	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—EGFR—ovarian cancer	4.91e-05	0.000551	CbGpPWpGaD
Estropipate—ALB—Folate Metabolism—TP53—ovarian cancer	4.85e-05	0.000545	CbGpPWpGaD
Estropipate—SLC22A1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	4.78e-05	0.000538	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—KRAS—ovarian cancer	4.66e-05	0.000524	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—KRAS—ovarian cancer	4.63e-05	0.000521	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	4.54e-05	0.00051	CbGpPWpGaD
Estropipate—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	4.53e-05	0.00051	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	4.53e-05	0.000509	CbGpPWpGaD
Estropipate—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	4.47e-05	0.000503	CbGpPWpGaD
Estropipate—ALB—Folate Metabolism—IL6—ovarian cancer	4.44e-05	0.000499	CbGpPWpGaD
Estropipate—ALB—Hemostasis—SPARC—ovarian cancer	4.35e-05	0.000489	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	4.34e-05	0.000488	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—ovarian cancer	4.33e-05	0.000487	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PPP1CC—ovarian cancer	4.31e-05	0.000485	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—BRIP1—ovarian cancer	4.31e-05	0.000485	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	4.3e-05	0.000483	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—PIK3CA—ovarian cancer	4.26e-05	0.000479	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—DOK1—ovarian cancer	4.25e-05	0.000478	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—NME2—ovarian cancer	4.19e-05	0.000471	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	4.18e-05	0.00047	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—TP53—ovarian cancer	4.14e-05	0.000466	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—YAP1—ovarian cancer	4.12e-05	0.000463	CbGpPWpGaD
Estropipate—ESR2—Generic Transcription Pathway—MYC—ovarian cancer	4.12e-05	0.000463	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	4.09e-05	0.000459	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	4.09e-05	0.000459	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—PIK3CG—ovarian cancer	4.08e-05	0.000459	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PPP1CC—ovarian cancer	3.99e-05	0.000449	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—HRAS—ovarian cancer	3.94e-05	0.000443	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	3.86e-05	0.000434	CbGpPWpGaD
Estropipate—ESR2—Gene Expression—ESR1—ovarian cancer	3.81e-05	0.000428	CbGpPWpGaD
Estropipate—SLC22A1—Transmembrane transport of small molecules—ABCB1—ovarian cancer	3.77e-05	0.000424	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—IL6—ovarian cancer	3.77e-05	0.000424	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—PGR—ovarian cancer	3.6e-05	0.000404	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—PIK3CD—ovarian cancer	3.59e-05	0.000403	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—NME2—ovarian cancer	3.58e-05	0.000403	CbGpPWpGaD
Estropipate—SLC22A1—Transmission across Chemical Synapses—MAPK1—ovarian cancer	3.56e-05	0.0004	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	3.56e-05	0.0004	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	3.55e-05	0.000399	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	3.54e-05	0.000398	CbGpPWpGaD
Estropipate—ALB—Selenium Micronutrient Network—IL6—ovarian cancer	3.52e-05	0.000396	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—AKT1—ovarian cancer	3.5e-05	0.000393	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—AKT1—ovarian cancer	3.48e-05	0.000391	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	3.43e-05	0.000386	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—PARP1—ovarian cancer	3.34e-05	0.000376	CbGpPWpGaD
Estropipate—ALB—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	3.31e-05	0.000372	CbGpPWpGaD
Estropipate—ALB—Metabolism—CYTB—ovarian cancer	3.3e-05	0.000371	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	3.22e-05	0.000363	CbGpPWpGaD
Estropipate—ALB—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	3.2e-05	0.00036	CbGpPWpGaD
Estropipate—ALB—Hemostasis—SOD1—ovarian cancer	3.16e-05	0.000355	CbGpPWpGaD
Estropipate—ALB—Hemostasis—PPP2R1A—ovarian cancer	3.14e-05	0.000353	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—PIK3CB—ovarian cancer	3.13e-05	0.000351	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	3.04e-05	0.000342	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—HDAC6—ovarian cancer	3.03e-05	0.00034	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	2.9e-05	0.000326	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	2.9e-05	0.000326	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—YAP1—ovarian cancer	2.89e-05	0.000325	CbGpPWpGaD
Estropipate—ALB—Metabolism—BRIP1—ovarian cancer	2.88e-05	0.000324	CbGpPWpGaD
Estropipate—ALB—Metabolism—PPP1CC—ovarian cancer	2.88e-05	0.000324	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—IL2—ovarian cancer	2.87e-05	0.000323	CbGpPWpGaD
Estropipate—SLC22A1—Transmission across Chemical Synapses—HRAS—ovarian cancer	2.85e-05	0.000321	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—NME2—ovarian cancer	2.76e-05	0.000311	CbGpPWpGaD
Estropipate—SLC22A1—Neuronal System—MAPK1—ovarian cancer	2.72e-05	0.000306	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—PPP2R1A—ovarian cancer	2.71e-05	0.000305	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—CYTB—ovarian cancer	2.7e-05	0.000304	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—YAP1—ovarian cancer	2.68e-05	0.000301	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	2.64e-05	0.000297	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—XIAP—ovarian cancer	2.62e-05	0.000295	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—SMARCA4—ovarian cancer	2.56e-05	0.000288	CbGpPWpGaD
Estropipate—ALB—Transmembrane transport of small molecules—ABCB1—ovarian cancer	2.53e-05	0.000284	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—EREG—ovarian cancer	2.5e-05	0.000281	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	2.48e-05	0.000278	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—VEGFA—ovarian cancer	2.44e-05	0.000274	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—BRIP1—ovarian cancer	2.36e-05	0.000265	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PPP1CC—ovarian cancer	2.36e-05	0.000265	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—FASN—ovarian cancer	2.36e-05	0.000265	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PGR—ovarian cancer	2.34e-05	0.000263	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—SLC5A5—ovarian cancer	2.32e-05	0.000261	CbGpPWpGaD
Estropipate—ALB—Hemostasis—CAV1—ovarian cancer	2.31e-05	0.00026	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—CYTB—ovarian cancer	2.31e-05	0.000259	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—MAPK3—ovarian cancer	2.31e-05	0.000259	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	2.26e-05	0.000254	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—SLC2A1—ovarian cancer	2.24e-05	0.000252	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—MAPK1—ovarian cancer	2.2e-05	0.000247	CbGpPWpGaD
Estropipate—SLC22A1—Neuronal System—HRAS—ovarian cancer	2.19e-05	0.000246	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PARP1—ovarian cancer	2.17e-05	0.000244	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—CYP1B1—ovarian cancer	2.15e-05	0.000241	CbGpPWpGaD
Estropipate—ALB—Hemostasis—PIK3CG—ovarian cancer	2.1e-05	0.000236	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	2.1e-05	0.000236	CbGpPWpGaD
Estropipate—ESR1—Generic Transcription Pathway—MYC—ovarian cancer	2.08e-05	0.000233	CbGpPWpGaD
Estropipate—ESR2—Gene Expression—MAPK3—ovarian cancer	2.04e-05	0.000229	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PPP1CC—ovarian cancer	2.02e-05	0.000227	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—BRIP1—ovarian cancer	2.02e-05	0.000227	CbGpPWpGaD
Estropipate—ESR2—Gene Expression—MYC—ovarian cancer	1.98e-05	0.000223	CbGpPWpGaD
Estropipate—ALB—Metabolism—YAP1—ovarian cancer	1.93e-05	0.000217	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.91e-05	0.000215	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—PIK3CA—ovarian cancer	1.91e-05	0.000214	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PPP2R1A—ovarian cancer	1.9e-05	0.000214	CbGpPWpGaD
Estropipate—ALB—Hemostasis—PIK3CD—ovarian cancer	1.85e-05	0.000208	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—CYTB—ovarian cancer	1.78e-05	0.0002	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—ABCB1—ovarian cancer	1.77e-05	0.000199	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PPP2R1A—ovarian cancer	1.76e-05	0.000198	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—TYMS—ovarian cancer	1.74e-05	0.000195	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.72e-05	0.000193	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.68e-05	0.000189	CbGpPWpGaD
Estropipate—ALB—Hemostasis—PIK3CB—ovarian cancer	1.61e-05	0.000181	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—YAP1—ovarian cancer	1.58e-05	0.000178	CbGpPWpGaD
Estropipate—ALB—Metabolism—FASN—ovarian cancer	1.58e-05	0.000177	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.57e-05	0.000176	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—BRIP1—ovarian cancer	1.56e-05	0.000175	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PPP1CC—ovarian cancer	1.56e-05	0.000175	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—AKT1—ovarian cancer	1.56e-05	0.000175	CbGpPWpGaD
Estropipate—ALB—Metabolism—SLC5A5—ovarian cancer	1.55e-05	0.000174	CbGpPWpGaD
Estropipate—ALB—Metabolism—SLC2A1—ovarian cancer	1.5e-05	0.000168	CbGpPWpGaD
Estropipate—ALB—Hemostasis—IL2—ovarian cancer	1.48e-05	0.000166	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.47e-05	0.000165	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.47e-05	0.000165	CbGpPWpGaD
Estropipate—ALB—Metabolism—CYP1B1—ovarian cancer	1.44e-05	0.000161	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—TERT—ovarian cancer	1.4e-05	0.000158	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—CAV1—ovarian cancer	1.4e-05	0.000157	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.38e-05	0.000155	CbGpPWpGaD
Estropipate—ESR2—Gene Expression—AKT1—ovarian cancer	1.37e-05	0.000154	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—YAP1—ovarian cancer	1.35e-05	0.000152	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.34e-05	0.000151	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CAV1—ovarian cancer	1.3e-05	0.000146	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—FASN—ovarian cancer	1.29e-05	0.000145	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PIK3CG—ovarian cancer	1.27e-05	0.000143	CbGpPWpGaD
Estropipate—ALB—Metabolism—PPP2R1A—ovarian cancer	1.27e-05	0.000143	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—SLC5A5—ovarian cancer	1.27e-05	0.000143	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.27e-05	0.000143	CbGpPWpGaD
Estropipate—ALB—Hemostasis—VEGFA—ovarian cancer	1.26e-05	0.000141	CbGpPWpGaD
Estropipate—ALB—Hemostasis—NRAS—ovarian cancer	1.24e-05	0.00014	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—IL6ST—ovarian cancer	1.23e-05	0.000138	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—SLC2A1—ovarian cancer	1.23e-05	0.000138	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.2e-05	0.000135	CbGpPWpGaD
Estropipate—ALB—Hemostasis—MAPK3—ovarian cancer	1.19e-05	0.000134	CbGpPWpGaD
Estropipate—ALB—Metabolism—ABCB1—ovarian cancer	1.18e-05	0.000133	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PIK3CG—ovarian cancer	1.18e-05	0.000133	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—APC—ovarian cancer	1.18e-05	0.000133	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.18e-05	0.000132	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—CYP1B1—ovarian cancer	1.18e-05	0.000132	CbGpPWpGaD
Estropipate—ALB—Metabolism—TYMS—ovarian cancer	1.16e-05	0.000131	CbGpPWpGaD
Estropipate—ALB—Hemostasis—MAPK1—ovarian cancer	1.13e-05	0.000127	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PIK3CD—ovarian cancer	1.12e-05	0.000126	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—FASN—ovarian cancer	1.1e-05	0.000124	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—SLC5A5—ovarian cancer	1.08e-05	0.000122	CbGpPWpGaD
Estropipate—ALB—Hemostasis—KRAS—ovarian cancer	1.07e-05	0.00012	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—SLC2A1—ovarian cancer	1.05e-05	0.000118	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—YAP1—ovarian cancer	1.04e-05	0.000117	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	1.04e-05	0.000117	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PIK3CD—ovarian cancer	1.04e-05	0.000117	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.04e-05	0.000117	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—MAPK3—ovarian cancer	1.03e-05	0.000115	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.03e-05	0.000115	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—CYP1B1—ovarian cancer	1e-05	0.000113	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—MYC—ovarian cancer	9.99e-06	0.000112	CbGpPWpGaD
Estropipate—ALB—Hemostasis—PIK3CA—ovarian cancer	9.82e-06	0.00011	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PIK3CB—ovarian cancer	9.77e-06	0.00011	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—ABCB1—ovarian cancer	9.68e-06	0.000109	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—TYMS—ovarian cancer	9.51e-06	0.000107	CbGpPWpGaD
Estropipate—ALB—Hemostasis—TP53—ovarian cancer	9.5e-06	0.000107	CbGpPWpGaD
Estropipate—ALB—Metabolism—CAV1—ovarian cancer	9.36e-06	0.000105	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—ERBB2—ovarian cancer	9.17e-06	0.000103	CbGpPWpGaD
Estropipate—ALB—Hemostasis—HRAS—ovarian cancer	9.09e-06	0.000102	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—MTOR—ovarian cancer	9.05e-06	0.000102	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PIK3CB—ovarian cancer	9.05e-06	0.000102	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	8.94e-06	0.000101	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PPP2R1A—ovarian cancer	8.91e-06	0.0001	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	8.87e-06	9.97e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CXCL8—ovarian cancer	8.69e-06	9.77e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—PIK3CG—ovarian cancer	8.53e-06	9.59e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—FASN—ovarian cancer	8.51e-06	9.57e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CDKN1B—ovarian cancer	8.49e-06	9.54e-05	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PTEN—ovarian cancer	8.44e-06	9.49e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—SLC5A5—ovarian cancer	8.37e-06	9.41e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CASP3—ovarian cancer	8.32e-06	9.35e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—IL2—ovarian cancer	8.31e-06	9.34e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—ABCB1—ovarian cancer	8.27e-06	9.3e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—TYMS—ovarian cancer	8.12e-06	9.13e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CCND1—ovarian cancer	8.1e-06	9.11e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—SLC2A1—ovarian cancer	8.09e-06	9.09e-05	CbGpPWpGaD
Estropipate—ALB—Hemostasis—AKT1—ovarian cancer	8.02e-06	9.02e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CTNNB1—ovarian cancer	8.02e-06	9.02e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—MMP9—ovarian cancer	7.86e-06	8.84e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PTEN—ovarian cancer	7.82e-06	8.79e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—CYP1B1—ovarian cancer	7.75e-06	8.72e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—CAV1—ovarian cancer	7.66e-06	8.61e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—PIK3CD—ovarian cancer	7.49e-06	8.43e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	7.32e-06	8.23e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—VEGFA—ovarian cancer	7.06e-06	7.94e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—STAT3—ovarian cancer	6.99e-06	7.86e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PIK3CG—ovarian cancer	6.98e-06	7.85e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—NRAS—ovarian cancer	6.97e-06	7.84e-05	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—AKT1—ovarian cancer	6.93e-06	7.79e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	6.88e-06	7.73e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—MAPK3—ovarian cancer	6.68e-06	7.51e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—CAV1—ovarian cancer	6.55e-06	7.36e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—PIK3CB—ovarian cancer	6.53e-06	7.34e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—MYC—ovarian cancer	6.5e-06	7.3e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—ABCB1—ovarian cancer	6.38e-06	7.18e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—MAPK1—ovarian cancer	6.35e-06	7.15e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—EGFR—ovarian cancer	6.35e-06	7.14e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—TYMS—ovarian cancer	6.27e-06	7.05e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	6.25e-06	7.03e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PIK3CD—ovarian cancer	6.13e-06	6.9e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—KRAS—ovarian cancer	6e-06	6.75e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PIK3CG—ovarian cancer	5.96e-06	6.7e-05	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PIK3CA—ovarian cancer	5.95e-06	6.69e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—PTEN—ovarian cancer	5.64e-06	6.35e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PIK3CA—ovarian cancer	5.51e-06	6.2e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PIK3CB—ovarian cancer	5.35e-06	6.01e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—TP53—ovarian cancer	5.33e-06	6e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PIK3CD—ovarian cancer	5.24e-06	5.89e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—HRAS—ovarian cancer	5.1e-06	5.74e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—CAV1—ovarian cancer	5.05e-06	5.68e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—IL6—ovarian cancer	4.88e-06	5.49e-05	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—AKT1—ovarian cancer	4.86e-06	5.47e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PTEN—ovarian cancer	4.62e-06	5.2e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PIK3CG—ovarian cancer	4.6e-06	5.17e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PIK3CB—ovarian cancer	4.57e-06	5.14e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—AKT1—ovarian cancer	4.5e-06	5.06e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PIK3CD—ovarian cancer	4.05e-06	4.55e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—PIK3CA—ovarian cancer	3.98e-06	4.48e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PTEN—ovarian cancer	3.95e-06	4.44e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PIK3CB—ovarian cancer	3.53e-06	3.96e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PIK3CA—ovarian cancer	3.26e-06	3.66e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—AKT1—ovarian cancer	3.25e-06	3.66e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PTEN—ovarian cancer	3.05e-06	3.43e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PIK3CA—ovarian cancer	2.79e-06	3.13e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—AKT1—ovarian cancer	2.66e-06	2.99e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—AKT1—ovarian cancer	2.28e-06	2.56e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PIK3CA—ovarian cancer	2.15e-06	2.42e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—AKT1—ovarian cancer	1.76e-06	1.97e-05	CbGpPWpGaD
